Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden (SEARCH-IPT)
Primary Purpose
Tuberculosis, HIV/AIDS
Status
Active
Phase
Not Applicable
Locations
Uganda
Study Type
Interventional
Intervention
SPIRIT Intervention
Sponsored by
About this trial
This is an interventional prevention trial for Tuberculosis
Eligibility Criteria
AIM 1 - Spirit Intervention:
Inclusion Criteria:
- District Health Officer or TB District Supervisor (or other DHO-appointed TB focal person) in Uganda.
- By definition, the DHO or TB District Supervisor are all ≥18 years of age.
Exclusion Criteria:
- Planned departure from position as DHO or TB District Supervisor prior to randomization.
- DHOs from Kampala and Wakiso districts, Uganda.
Sites / Locations
- Infectious Diseases Research Collaboration
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Aim 1: DHO Intervention Arm
Aim 1: DHO Control Arm
Arm Description
A selection of DHO or TB district supervisors that are randomized to the multicomponent SPIRIT intervention.
A selection of DHO or TB district supervisors that are randomized to the country standard of care, but not to receive the study intervention.
Outcomes
Primary Outcome Measures
IPT Uptake
Rate at which eligible HIV-infected adults receive a prescription for INH
Secondary Outcome Measures
Full Information
NCT ID
NCT03315962
First Posted
September 26, 2017
Last Updated
October 14, 2022
Sponsor
University of California, San Francisco
Collaborators
Makerere University, National Institute of Allergy and Infectious Diseases (NIAID), Cipla Ltd.
1. Study Identification
Unique Protocol Identification Number
NCT03315962
Brief Title
Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden
Acronym
SEARCH-IPT
Official Title
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
November 15, 2017 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
September 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
Makerere University, National Institute of Allergy and Infectious Diseases (NIAID), Cipla Ltd.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The overall objective of this study is to determine if a multi-component implementation intervention (SPIRIT) and additional leadership and management training that targets District Health Officers (DHOs) can increase IPT initiation among HIV-infected persons, as compared to country standard practices, in a cluster randomized trial in Uganda.
Detailed Description
The failure to use isoniazid (INH) preventative therapy (IPT) in HIV-infected individuals in Sub-Saharan Africa represents one of the single biggest implementation gaps between evidence and practice in today's response to the HIV epidemic. The proposed study will evaluate the effectiveness of a multi-component intervention to improve IPT uptake in two regions of Uganda. The study design is a randomized controlled trial (RCT) where the unit of randomization is clusters of districts in Uganda. The clusters consist of 5-7 districts and the District Health Officer (DHO) and District TB and Leprosy Supervisor (DTLS) from each district is invited to participate. The SPIRIT intervention is based on the PRECEDE framework which outlines the importance of social networks, social influence, and behavior change.
The SEARCH-IPT multi-component intervention includes:
A teaching collaborative which will be formed within the randomized clusters of district DHOs and DTLSs to create a mini-collaborative, which will be led by an opinion leader with HIV and TB expertise, to spread new scientific knowledge about IPT and the clinical ability to rule out TB, and to facilitate discussion between DHOs.
A "toolkit" of options to ease IPT implementation will support DHOs to scale up IPT through the study of the comparative effectiveness of material contributions to their day-to-day function of managing front line providers and clinics.
A reporting collaborative comprised of the teaching collaborative groups, will define targets as a group, and reconvening every 6 months for 3 years (with the additional option of 36 months for a final report back), where each collaborative has an opportunity to share progress and results.
In addition, an enhanced business training & 'training-of-trainers' curriculum will be conducted to evaluate the effect of enhanced business training among intervention group DHOs from Phase 1 (Years 1-3 of trial follow-up) in the southwestern Uganda region on IPT initiation during years 4-5 of trial follow-up (Phase 2).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tuberculosis, HIV/AIDS
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
468 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Aim 1: DHO Intervention Arm
Arm Type
Experimental
Arm Description
A selection of DHO or TB district supervisors that are randomized to the multicomponent SPIRIT intervention.
Arm Title
Aim 1: DHO Control Arm
Arm Type
No Intervention
Arm Description
A selection of DHO or TB district supervisors that are randomized to the country standard of care, but not to receive the study intervention.
Intervention Type
Behavioral
Intervention Name(s)
SPIRIT Intervention
Intervention Description
The intervention will include implementing a teaching collaborative among group of DHOs and TB Supervisors, enabling text messaging between DHOs and front line providers, and establishing a report collaborative where DHOs will receive feedback on the performance of their district in administering IPT compared to other districts.
Primary Outcome Measure Information:
Title
IPT Uptake
Description
Rate at which eligible HIV-infected adults receive a prescription for INH
Time Frame
12-36 Months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
AIM 1 - Spirit Intervention:
Inclusion Criteria:
District Health Officer or TB District Supervisor (or other DHO-appointed TB focal person) in Uganda.
By definition, the DHO or TB District Supervisor are all ≥18 years of age.
Exclusion Criteria:
Planned departure from position as DHO or TB District Supervisor prior to randomization.
DHOs from Kampala and Wakiso districts, Uganda.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Diane Havlir, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Gabriel Chamie, MD, MPH
Organizational Affiliation
University of California, San Francisco
Official's Role
Study Chair
Facility Information:
Facility Name
Infectious Diseases Research Collaboration
City
Kampala
Country
Uganda
12. IPD Sharing Statement
Citations:
PubMed Identifier
35908553
Citation
Kakande E, Christian C, Balzer LB, Owaraganise A, Nugent JR, DiIeso W, Rast D, Kabami J, Johnson Peretz J, Camlin CS, Shade SB, Geng EH, Kwarisiima D, Kamya MR, Havlir DV, Chamie G. A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial. Lancet HIV. 2022 Sep;9(9):e607-e616. doi: 10.1016/S2352-3018(22)00166-7. Epub 2022 Jul 28.
Results Reference
result
Learn more about this trial
Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden
We'll reach out to this number within 24 hrs